Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Upstream Bio (UPB) EBIT Margin (2023 - 2025)

Upstream Bio has reported EBIT Margin over the past 3 years, most recently at 6911.23% for Q4 2025.

  • Quarterly results put EBIT Margin at 6911.23% for Q4 2025, down 261792.0% from a year ago — trailing twelve months through Dec 2025 was 5618.82% (down 233763.0% YoY), and the annual figure for FY2025 was 5618.82%, down 233763.0%.
  • EBIT Margin for Q4 2025 was 6911.23% at Upstream Bio, down from 5539.39% in the prior quarter.
  • Over the last five years, EBIT Margin for UPB hit a ceiling of 1511.43% in Q3 2023 and a floor of 6911.23% in Q4 2025.
  • Median EBIT Margin over the past 3 years was 3866.26% (2024), compared with a mean of 4072.62%.
  • Biggest five-year swings in EBIT Margin: plummeted -110887bps in 2024 and later tumbled -331023bps in 2025.
  • Upstream Bio's EBIT Margin stood at 3184.44% in 2023, then crashed by -35bps to 4293.31% in 2024, then crashed by -61bps to 6911.23% in 2025.
  • The last three reported values for EBIT Margin were 6911.23% (Q4 2025), 5539.39% (Q3 2025), and 4732.87% (Q2 2025) per Business Quant data.